Holen Sie sich die Stockscreener-App
0.923
1.26%
0.0115
Schlusskurs vom Vortag:
$0.9115
Offen:
$0.926
24-Stunden-Volumen:
39,762
Relative Volume:
0.53
Marktkapitalisierung:
$50.47M
Einnahmen:
$118.18M
Nettoeinkommen (Verlust:
$5.99M
KGV:
6.9977
EPS:
0.1319
Netto-Cashflow:
$-12.91M
1W Leistung:
-0.97%
1M Leistung:
-7.05%
6M Leistung:
-36.78%
1J Leistung:
-44.73%
1-Tages-Spanne:
$0.9201
$0.94
1-Wochen-Bereich:
$0.9002
$0.9699
52-Wochen-Spanne:
$0.68
$1.7799
Intercure Ltd Stock (INCR) Company Profile
Vergleichen Sie INCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.923 | 49.84M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
124.82 | 53.64B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.23 | 54.24B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
10.47 | 45.87B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.08 | 37.94B | 17.39B | 1.43B | 774.28M | 1.219 |
|
UTHR
United Therapeutics Corp
|
469.49 | 20.14B | 3.13B | 1.27B | 1.12B | 26.39 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
Quarterly Trades: Is InterCure Ltd exposed to currency risks2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Does InterCure Ltd. stock benefit from AI growthWeekly Profit Report & Risk Controlled Daily Trade Plans - mfd.ru
RSI Check: Is InterCure Ltd undervalued by DCF analysisMarket Movers & Low Risk Entry Point Tips - baoquankhu1.vn
Surprises Report: Is InterCure Ltd a potential multi baggerWeekly Loss Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge - simplywall.st
Will InterCure Ltd. stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Published on: 2026-01-12 07:36:04 - ulpravda.ru
Can InterCure Ltd. stock attract ESG capital inflows2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Улправда
Will InterCure Ltd. stock attract ESG investorsJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Why InterCure Ltd. stock appeals to dividend seekersTrade Exit Summary & Verified Entry Point Signals - Newser
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com Nigeria
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv By Investing.com - Investing.com South Africa
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Why InterCure Ltd. stock remains undervaluedJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):